Study of the Osteoprotector Effects of a Milk Product Based on Anthocyans and Enriched in Calcium and Vitamin D
NCT ID: NCT00663221
Last Updated: 2009-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
56 participants
INTERVENTIONAL
2008-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Proteins Fraction Derived From Milk on Osteoporosis Prevention
NCT01478724
Nutritional Supplement and Bone Health in Post-Menopausal Women
NCT03337971
Milk Protein and Bone Health in Postmenopausal Women
NCT03701113
Profylactic Treatment for Patients in Risk Osteoporosis
NCT05787808
Design and Development of a Novel Food Supplement for Osteoporosis Based on Gut Microbiome Mechanisms
NCT05421819
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
placebo
2
Anthocyans, Calcium and Vitamin D
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anthocyans, Calcium and Vitamin D
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 50 and 65 years
* Between 1 and 5 years menopause
* IMC between 19 and 30 kg/m²
Exclusion Criteria
* Vitamin D not including in the range of 20nmoles\<25(OH)\<100nmoles/l
* Vegan and vegetarian diet
* Regular consumption of food supplementary benefits
* Lactose intolerance
* While dieting
50 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Elvir SAS
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Clermont-Ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LC2 Atlas
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.